Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronic interstitial lung disease characterized by progressive scarring of lung ...

Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses. Scientists believe key immune elements – cells and genes – may explain resolution ...

Researchers reveal how targeting HIF2 could transform the treatment of idiopathic pulmonary fibrosis (IPF), offering hope for ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in ...

Idiopathic pulmonary fibrosis (IPF) and diabetes mellitus do not appear to have a causal association, according to study findings published in Thorax.

The stars of Broadway will perform show tunes in the Pulmonary Fibrosis Foundation’s (PFF) 15th annual Broadway Belts for PFF ...

In a challenging year for biotechnology firms, PureTech Health PLC (PRTC) stock has touched a 52-week low, dipping to $16.81.

Leerink Partners analyst Faisal Khurshid has reiterated their bullish stance on PLRX stock, giving a Buy rating on January 15.Stay Ahead of ...

RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from deadly lung diseases characterized by pulmonary inflammation, is pleased to announce ...

Clare Donohoe, Trustee of Pulmonary Fibrosis Northern Ireland, recently visited Balcas Timber Limited to present a certificate of appreciation ...